HCSGD entry for SRSF1
1. General information
Official gene symbol | SRSF1 |
---|---|
Entrez ID | 6426 |
Gene full name | serine/arginine-rich splicing factor 1 |
Other gene symbols | ASF SF2 SF2p33 SFRS1 SRp30a |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
![color bar](img/red_blue.jpg)
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000166 | Nucleotide binding | IEA | molecular_function |
GO:0000395 | MRNA 5'-splice site recognition | IDA | biological_process |
GO:0000398 | MRNA splicing, via spliceosome | IC TAS | biological_process |
GO:0001701 | In utero embryonic development | IEA | biological_process |
GO:0003676 | Nucleic acid binding | IEA | molecular_function |
GO:0003723 | RNA binding | IDA IPI | molecular_function |
GO:0003729 | MRNA binding | IDA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005654 | Nucleoplasm | IDA TAS | cellular_component |
GO:0005737 | Cytoplasm | IEA | cellular_component |
GO:0006366 | Transcription from RNA polymerase II promoter | TAS | biological_process |
GO:0006369 | Termination of RNA polymerase II transcription | TAS | biological_process |
GO:0006376 | MRNA splice site selection | TAS | biological_process |
GO:0006397 | MRNA processing | TAS | biological_process |
GO:0006406 | MRNA export from nucleus | TAS | biological_process |
GO:0008380 | RNA splicing | IEA TAS | biological_process |
GO:0010467 | Gene expression | TAS | biological_process |
GO:0016607 | Nuclear speck | IDA IEA | cellular_component |
GO:0031124 | MRNA 3'-end processing | TAS | biological_process |
GO:0035145 | Exon-exon junction complex | IDA | cellular_component |
GO:0050733 | RS domain binding | IEA | molecular_function |
GO:0060048 | Cardiac muscle contraction | IEA | biological_process |
GO:0071013 | Catalytic step 2 spliceosome | IDA | cellular_component |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.9805117625 | 0.0153233806 | 0.9999902473 | 0.2431143460 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.1797932942 |
GSE13712_SHEAR | Up | 0.2863549455 |
GSE13712_STATIC | Up | 0.1811902150 |
GSE19018 | Down | -0.5413586107 |
GSE19899_A1 | Down | -0.3382910268 |
GSE19899_A2 | Down | -0.5966835556 |
PubMed_21979375_A1 | Down | -0.3955701192 |
PubMed_21979375_A2 | Down | -0.6099463694 |
GSE35957 | Down | -0.5197971071 |
GSE36640 | Down | -0.3052448695 |
GSE54402 | Up | 0.0761847279 |
GSE9593 | Down | -0.4283411449 |
GSE43922 | Down | -0.2855113657 |
GSE24585 | Down | -0.0743259922 |
GSE37065 | Down | -0.0441641189 |
GSE28863_A1 | Down | -0.3069516041 |
GSE28863_A2 | Down | -0.4109300074 |
GSE28863_A3 | Down | -0.6177121582 |
GSE28863_A4 | Up | 0.2148648555 |
GSE48662 | Down | -0.0506984959 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-10b-5p | MIMAT0000254 | MIRT006539 | Luciferase reporter assay | Functional MTI | 21118818 |
hsa-miR-10a-5p | MIMAT0000253 | MIRT006536 | Luciferase reporter assay | Functional MTI | 21118818 |
hsa-miR-7-5p | MIMAT0000252 | MIRT004497 | qRT-PCR//Luciferase reporter assay//Western blot//Northern blot | Functional MTI | 20385090 |
hsa-miR-505-3p | MIMAT0002876 | MIRT016250 | Reporter assay;Western blot | Functional MTI | 20923760 |
hsa-miR-103a-3p | MIMAT0000101 | MIRT027043 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-16-5p | MIMAT0000069 | MIRT031783 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-744-5p | MIMAT0004945 | MIRT037540 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-193b-3p | MIMAT0002819 | MIRT041396 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-423-3p | MIMAT0001340 | MIRT042557 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-149-5p | MIMAT0000450 | MIRT045599 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-10a-5p | MIMAT0000253 | 1 | hsa-miR-10a | {Western blot} | {downregulation by anti-miRNA} | 21118818 | |
hsa-miR-10b-5p | MIMAT0000254 | 1 | hsa-miR-10b | {Western blot} | {downregulation by anti-miRNA} | 21118818 | |
hsa-miR-10a-5p | MIMAT0000253 | NA | hsa-miR-10a | {Western blot} | {overexpression} | 20506192 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 3 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
23478443 | Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence |
23478443 | We report that the oncogenic splicing factor SRSF1, which is overexpressed in many cancers, stabilizes the tumor suppressor protein p53 by abrogating its MDM2-dependent proteasomal degradation |
23478443 | We show that SRSF1 is a necessary component of an MDM2/ribosomal protein complex, separate from the ribosome, that functions in a p53-dependent ribosomal-stress checkpoint pathway |
23478443 | Consistent with the stabilization of p53, increased SRSF1 expression in primary human fibroblasts decreases cellular proliferation and ultimately triggers oncogene-induced senescence (OIS) |
23478443 | These findings underscore the deleterious outcome of SRSF1 overexpression and identify a cellular defense mechanism against its aberrant function |
22470345 | The Splicing Factor SRSF1 as a Marker for Endothelial Senescence |
22470345 | Based on its senescence-dependent involvement in alternative splicing, we postulate that SRSF1 is a key marker of EC senescence, regulating the expression of alternative isoforms of target genes such as endoglin (ENG), vascular endothelial growth factor A (VEGFA), tissue factor (T3), or lamin A (LMNA) that integrate in a common molecular senescence program |
12209876 | We have found that increasing the ratio of either hnRNP A1 or A2 over that of splicing factor SF2/ASF results in the preferential generation of the p14(ARF) isoform |
12209876 | A constitutive decrease in the ratio of hnRNP A1 or A2 to SF2/ASF in senescent fibroblasts is typically accompanied by an increase in the level of p16(INK4a) isoform |
Entries Per Page
Displaying Page of